FDA clears Bayer’s Gadavist as first contrast agent for cardiac MRIBayer’s Gadavist has become the first imaging agent approved in the US to detect blockages in the hearts Share XFDA clears Bayer’s Gadavist as first contrast agent for cardiac MRIhttps://pharmaphorum.com/news/fda-clears-bayers-gadavist-as-first-contrast-agent-for-cardiac-mri/
Gilead’s R&D chief to step down as new CEO O’Day rings the changesGilead’s chief scientific officer, John McHutchison is to leave the company at the beginning of next month during Share XGilead’s R&D chief to step down as new CEO O’Day rings the changeshttps://pharmaphorum.com/news/gileads-rd-chief-to-step-down-as-new-ceo-oday-rings-the-changes/
Novartis ups 2019 guidance after strong Q2Novartis has revised its guidance for 2019 upwards after a strong set of Q2 figures, with its psoriasis Share XNovartis ups 2019 guidance after strong Q2https://pharmaphorum.com/news/novartis-ups-2019-guidance-after-strong-q2/
The future of clinical trials innovationMedidata is engaging with regulators to advise on the future of clinical trials, but CEO Tarek Sherif cautions Share XThe future of clinical trials innovationhttps://pharmaphorum.com/r-d/views-analysis-r-d/the-future-of-clinical-trials-innovation/
Why pharma needs honest patient dialogueAstellas Pharma US president Percival Barretto-Ko talks with Dr Paul Tunnah about drug pricing, collaboration and improving the Share XWhy pharma needs honest patient dialoguehttps://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019/astellas-pharma-percival-barretto-ko/
The importance of pharma CSRThe industry is increasingly aware of the importance of corporate social responsibility (CSR) programmes – and Alex Kalomparis, Share XThe importance of pharma CSRhttps://pharmaphorum.com/r-d/views-analysis-r-d/the-importance-of-pharma-csr/
Why pharma needs honest patient dialogueAstellas Pharma US president Percival Barretto-Ko talks with Dr Paul Tunnah about drug pricing, collaboration and improving the Share XWhy pharma needs honest patient dialoguehttps://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019/astellas-pharma-percival-barretto-ko/
Deep Dive: Oncology and ASCO 2019Oncology is currently a more cutting-edge, dynamic field than it has ever been – as demonstrated at this Share XDeep Dive: Oncology and ASCO 2019https://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019
Time to fix pharma’s outdated business modelThe disconnect between payers and pharma companies is just one symptom of pharma’s outdated business model, according to Share XTime to fix pharma’s outdated business modelhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/janssen-kris-sterkens-pharma-business-model/
Innovative contracting in Europe – a Trojan horse? Share XInnovative contracting in Europe – a Trojan horse?https://pharmaphorum.com/market-access-2/innovative-contracting-in-europe-a-trojan-horse/
How pharma marketing can stay ahead of the evolving customer journey Share XHow pharma marketing can stay ahead of the evolving customer journeyhttps://pharmaphorum.com/digital/how-pharma-marketing-can-stay-ahead-of-the-evolving-customer-journey/
Launch excellence in a disrupted world – challenges & opportunities Share XLaunch excellence in a disrupted world – challenges & opportunitieshttps://pharmaphorum.com/market-access-2/launch-excellence-in-a-disrupted-world-challenges-opportunities/
Tell us: how fast is pharma innovatingpharmaphorum is conducting some research into how pharmaceutical marketers are innovating amidst the increasing demands of engaging in Share XTell us: how fast is pharma innovatinghttps://pharmaphorum.com/sales-marketing/tell-us-how-fast-is-pharma-innovating/
How to optimise pharma’s digital HCP engagementPharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if Share XHow to optimise pharma’s digital HCP engagementhttps://pharmaphorum.com/debates-insight-sales-marketing/how-to-optimise-pharmas-digital-hcp-engagement/
A blueprint for healthcare: Brand strategy and planningWhen pharmaceutical and biotech companies are working on their brand strategy and conducting brand planning it is vital Share XA blueprint for healthcare: Brand strategy and planninghttps://pharmaphorum.com/sales-marketing/a-blueprint-for-healthcare-brand-strategy-and-planning/
Addressing global health challenges: the pharmaphorum podcast Share XAddressing global health challenges: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/iavi-global-health-challenges/
ASCO 2019 – Kantar considers MacroGenics’ phase 3 SOPHIA trial Share XASCO 2019 – Kantar considers MacroGenics’ phase 3 SOPHIA trialhttps://pharmaphorum.com/spotlight/asco-2019-and-the-future-of-oncology/kantar-macrogenics-phase-3-sophia-trial/
ASCO 2019 – phase I data generates hope for the future Share XASCO 2019 – phase I data generates hope for the futurehttps://pharmaphorum.com/spotlight/asco-2019-and-the-future-of-oncology/amgen-kras-amg510-phase-i-data/
Three Interactive Sessions to take place at the Respiratory Drug Delivery Conference Share XThree Interactive Sessions to take place at the Respiratory Drug Delivery Conferencehttps://pharmaphorum.com/partner-content/three-interactive-sessions-to-take-place-at-the-respiratory-drug-delivery-conference/
Exclusive interview with AstraZeneca ahead of upcoming Wearable Injectors & Connected Devices Share XExclusive interview with AstraZeneca ahead of upcoming Wearable Injectors & Connected Deviceshttps://pharmaphorum.com/partner-content/exclusive-interview-with-astrazeneca-ahead-of-upcoming-wearable-injectors-connected-devices/
Speaker Interview with iVeena Released for 3rd Ophthalmic Drugs Conference Share XSpeaker Interview with iVeena Released for 3rd Ophthalmic Drugs Conferencehttps://pharmaphorum.com/partner-content/speaker-interview-with-iveena-released-for-3rd-ophthalmic-drugs-conference/
Amgen on the role of RWE in a Product Evidence Generation Plan Share XAmgen on the role of RWE in a Product Evidence Generation Planhttps://pharmaphorum.com/partner-content/amgen-on-the-role-of-rwe-in-a-product-evidence-generation-plan/
pharmaphorum welcomes George Underwood to its editorial helm Share Xpharmaphorum welcomes George Underwood to its editorial helmhttps://pharmaphorum.com/news/pharmaphorum-welcomes-george-underwood-to-its-editorial-helm/
STEM Healthcare appoints Jason McKenna as CEO Share XSTEM Healthcare appoints Jason McKenna as CEOhttps://pharmaphorum.com/partner-content/stem-healthcare-appoints-jason-mckenna-as-ceo/
